Glucagon-like peptide-1 levels on admission for acute myocardial infarction with or without acute hyperglycemia

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1214-1216

  Konishi, Masaaki ^a   Akiyama, Eiichi ^a   Matsuzawa, Yasushi ^b   Suzuki, Hiroyuki ^a   Maejima, Nobuhiko ^a   Iwahashi, Noriaki ^a   Tsukahara, Kengo ^a   Hibi, Kiyoshi ^a   Kosuge, Masami ^a   Ebina, Toshiaki ^a   Umemura, Satoshi ^c   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b Mayo Clinic College of Medicine   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Diabetes; Hyperglycemia; Incretin

Indexed keywords

BIOLOGICAL MARKER; GLUCAGON LIKE PEPTIDE 1;

ACUTE DISEASE; BLOOD; COMPLICATION; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS;

ACUTE DISEASE; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS;

EID: 84908252688     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.221     Document Type: Article

References (10)

1. S.E. Capes, D. Hunt, K. Malmberg, and H.C. Gerstein Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
2. M. Kosiborod, S.S. Rathore, and S.E. Inzucchi Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes Circulation 111 2005 3078 3086
3. J.S. Woo, W. Kim, and S.J. Ha Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study Arterioscler Thromb Vasc Biol 33 2013 2252 2260
4. L.A. Nikolaidis, S. Mankad, and G.G. Sokos Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965
5. J. Lonborg, N. Vejlstrup, and H. Kelbaek Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
6. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction Circulation 126 2012 2020 2035
7. S. Lee, D. Yabe, and K. Nohtomi Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes Endocr J 57 2010 119 126
8. E.P. Smith, Z. An, and C. Wagner The role of beta cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs Cell Metab 19 2014 1050 1057
9. M. Ishihara Acute hyperglycemia in patients with acute myocardial infarction Circ J 76 2012 563 571
10. G.A. Oswald, C.C. Smith, D.J. Betteridge, and J.S. Yudkin Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction Br Med J (Clinical research ed) 293 1986 917 922